Published in Parasit Vectors on December 15, 2015
Artemisinin-Resistant Plasmodium falciparum Malaria. Microbiol Spectr (2016) 0.83
Prevalence of K13-propeller gene polymorphisms among Plasmodium falciparum parasites isolated from adult symptomatic patients in northern Uganda. BMC Infect Dis (2016) 0.75
Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine. Malar J (2016) 0.75
Lack of artemisinin resistance in Plasmodium falciparum in northwest Benin after 10 years of use of artemisinin-based combination therapy. Parasite (2016) 0.75
Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes. Malar J (2016) 0.75
Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2009) 33.25
Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med (2008) 17.65
Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature (2002) 12.09
Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2014) 11.87
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet (2012) 11.82
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature (2013) 11.03
Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet (2005) 8.30
Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis (2015) 5.50
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet (2013) 5.22
Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am J Trop Med Hyg (2007) 4.51
Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis (2014) 4.24
Early origin and recent expansion of Plasmodium falciparum. Science (2003) 4.07
Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA (2007) 3.62
Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science (2014) 3.41
A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. Am J Trop Med Hyg (2007) 3.38
Chromosome-wide SNPs reveal an ancient origin for Plasmodium falciparum. Nature (2002) 3.23
Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study. J Infect Dis (2014) 3.21
Artemisinin-based combinations. Curr Opin Infect Dis (2005) 2.51
K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa. J Infect Dis (2014) 2.16
Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children. PLoS One (2014) 1.96
No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali. Am J Trop Med Hyg (2012) 1.87
Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013. Malar J (2014) 1.49
Mutations in Plasmodium falciparum K13 propeller gene from Bangladesh (2009-2013). Malar J (2014) 1.48
Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam. Antimicrob Agents Chemother (2014) 1.48
Genetic structure of Plasmodium falciparum and elimination of malaria, Comoros archipelago. Emerg Infect Dis (2010) 1.27
Plasmodium falciparum resistant to chloroquine and to pyrimethamine in Comoros. Parasite (2004) 1.09
Novel mutations in K13 propeller gene of artemisinin-resistant Plasmodium falciparum. Emerg Infect Dis (2015) 1.07
Lack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins. Antimicrob Agents Chemother (2012) 1.01
[Surveillance of falciparum malaria susceptibility to antimalarial drugs and policy change in the Comoros]. Bull Soc Pathol Exot (2007) 1.01
Polymorphisms in Plasmodium falciparum K13-propeller in Angola and Mozambique after the introduction of the ACTs. PLoS One (2015) 1.01
Antimalarial drug resistance in Africa: key lessons for the future. Ann N Y Acad Sci (2015) 1.00
In-vivo efficacy of amodiaquine-artesunate in children with uncomplicated Plasmodium falciparum malaria in western Kenya. Trop Med Int Health (2009) 0.95
[Epidemiology and control of malaria in the Federal Islamic Republic of Comoros]. Sante (1996) 0.86
K13-Propeller Polymorphisms in Plasmodium falciparum Isolates from Patients in Mayotte in 2013 and 2014. Antimicrob Agents Chemother (2015) 0.85
Artemisinin resistance-associated polymorphisms at the K13-propeller locus are absent in Plasmodium falciparum isolates from Haiti. Am J Trop Med Hyg (2015) 0.82
Is the A578S Single-Nucleotide Polymorphism in K13-propeller a Marker of Emerging Resistance to Artemisinin Among Plasmodium falciparum in Africa? J Infect Dis (2015) 0.79
Tracing the geographic origins of Plasmodium falciparum malaria parasites. Pathog Glob Health (2014) 0.77